Model N

Model N develops cloud-based revenue management and compliance software for the pharmaceutical, medical technology, and high-tech industries. The company has been operating for more than 25 years and serves customers across these sectors by providing tools to manage pricing, contracting, channel operations, and regulatory compliance. Its platform covers processes spanning sales, marketing, channels, finance, and legal functions, with the stated goal of helping customers maximize revenue and maintain compliance throughout the product and commercial lifecycle.

Model N organizes its offerings into three primary industry solution sets — Revenue Cloud for Pharma, Revenue Cloud for Medtech, and Revenue Cloud for High Tech — alongside Business Services for Life Sciences. The platform is delivered as cloud-based software and is supplemented by data-driven insights and value-added services.

Pharma Products

• Provider Management: manages contracting and pricing relationships with healthcare providers.
• Payer Management: handles pricing and contract management with payers.
• Validata: a data validation and management product for pharma revenue processes.
• 340B Vigilance: supports compliance with the 340B drug pricing program.
• Government Pricing: automates calculation and reporting of government-mandated prices.
• Medicaid: manages Medicaid rebate calculations and submissions.
• State Price Transparency Management: addresses state-level drug price reporting requirements.
• Global Pricing Management: supports pricing strategy and execution across international markets.
• Global Tender Management: manages tender processes in global markets.
• Intelligence Cloud: provides data analytics and insights across revenue operations.
• Formulary Compliance: monitors and manages formulary positioning and compliance.
• Data nSights: delivers data analytics capabilities to support revenue decision-making.

Medtech Products

• Provider Management: manages provider contracts and pricing for medical technology companies.
• Deal Management for Life Sciences: supports the creation and management of commercial deals.
• Global Tender Management: handles international tender processes for medtech products.
• Intelligence Cloud: analytics and insights capabilities tailored to medtech revenue operations.
• Syndicated Customer Master: provides a unified, standardized customer data foundation.
• Data nSights: analytics tools for revenue and commercial performance visibility.

High Tech Products

• Channel Data Management: collects and manages point-of-sale and inventory data from channel partners.
• Channel Management: supports the management of relationships and programs with channel partners.
• Deal Intelligence: provides analytics and guidance to support deal pricing decisions.
• Deal Management for High Tech: manages the end-to-end deal approval and pricing process.
• Intelligence Cloud: analytics and insights for high-tech revenue and channel operations.
• Market Development Fund Management: administers and tracks market development fund programs with partners.
• Payment Management: automates the calculation and processing of channel payments and incentives.
• Price Intelligence: monitors and analyzes market pricing data to inform pricing strategy.
• Rebate Management: manages rebate program design, accrual, and settlement with channel partners.

Services and Support

• Professional Services: implementation and project-based services to support deployment and configuration.
• Advisory Services: strategic guidance to help customers realize business value from the platform.
• Expert Services: includes Business Services, Application Services, Value Realization Services, and Education Services.
• Support: ongoing product support accessible through a Customer Success Portal and Knowledge Center.

Company and Compliance Context

• Model N has operated for more than 25 years serving pharmaceutical, medtech, and high-tech companies.
• The platform is delivered as cloud-based software, supporting digital transformation of commercial and revenue operations.
• The company publishes an annual State of Revenue Report covering trends in revenue management and compliance; the 2026 edition notes that 96% of pharma leaders believe addressing gross-to-net issues early would materially impact profit margins.
• Model N maintains European operations and has a partner ecosystem, with resources including case studies, whitepapers, webinars, and industry events.

Model N's platform addresses the full gross-to-net lifecycle for life sciences companies, covering government and commercial pricing compliance, channel incentive management, and global market operations, while also serving high-tech manufacturers with channel and deal management capabilities.